Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons learned concerning vaccine safety.

S A Plotkin1

  • 1Wistar Institute, University of Pennsylvania, Aventis Pasteur, 4650 Wismer Road, Doylestown, PA 18901, USA. stanley.plotkin@aventis.com

Vaccine
|October 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zika as still another argument for a new path to vaccine development.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

Building on the success of the Expanded Programme on Immunization: enhancing the focus on disease prevention and control.

Vaccine·2011
Same author

WITHDRAWN: Letter to the Editor.

Vaccine·2011
Same author

Human cytomegalovirus vaccine is an orphan.

Developments in biologicals·2002
Same author

Conclusions to the conference on orphan vaccines.

Developments in biologicals·2002
Same author

John Snow learns from Louis Pasteur.

The Pediatric infectious disease journal·2001
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
Same journal

V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023.

Vaccine·2026
Same journal

In silico selection and in vivo evaluation of scoloptoxin SSD14, Rm-inositol monophosphatase, and Rm-neprilysin as potential anti-tick vaccines.

Vaccine·2026
See all related articles

Investigating vaccine safety is crucial, even when links between vaccines and adverse events seem unlikely. Rigorous scientific inquiry into these concerns benefits public trust and understanding of vaccine safety.

Area of Science:

  • Immunology
  • Public Health
  • Medical History

Background:

  • Vaccine safety has been a persistent public concern since Edward Jenner's pioneering work.
  • Addressing public apprehension regarding vaccine safety is essential for maintaining high vaccination rates.

Purpose of the Study:

  • To emphasize the necessity of thoroughly investigating all proposed links between vaccines and adverse reactions.
  • To highlight the value of scientific rigor in vaccine safety research, regardless of the outcome.
  • To derive lessons for future vaccine safety practices based on recent experiences.

Main Methods:

  • Review of historical and recent vaccine safety investigations.
  • Analysis of the scientific process involved in evaluating vaccine-adverse event relationships.

Related Experiment Videos

  • Synthesis of experiences to formulate future recommendations.

    • Main Results:

    • Many proposed vaccine-adverse event relationships warrant thorough investigation, as some have been substantiated.
    • Studies refuting a link between vaccines and adverse events demonstrate scientific integrity and educate the public.
    • Eight key lessons for future vaccine safety protocols have been identified.

    Conclusions:

    • Continuous and rigorous investigation of vaccine safety concerns is paramount.
    • Transparency and scientific rigor in vaccine safety research build public confidence.
    • Learning from past investigations is vital for advancing future vaccine safety strategies.